Illustrative

Donald Trump backs down from 250% EU pharma tariff in deal

BBC·Aug 22

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A deal has been reached in which a 250% tariff on eu pharma has been backed down from. The move is reportedly part of a larger agreement. The terms of the deal and its implications are not fully detailed in available reports.

Full coverage

U.S. and E.U. trade deal caps tariffs on exports at 15%

NBC News·Aug 21

Trump’s EU pharma tariffs will be limited to 15%, exempts generics

Medical Marketing and Media·Aug 21

Trump tariffs live updates: Trump unveils tariffs on timber, lumber, furniture; Pfizer set for reprieve

Yahoo Finance·Sep 30

U.S. to impose 100% tariff on branded, patented drugs unless firms build plants locally, Trump says

CNBC·Sep 25

Fetching the latest headlines…

Donald Trump backs down from 250% EU pharma tariff in deal

Full coverage

U.S. and E.U. trade deal caps tariffs on exports at 15%

Trump’s EU pharma tariffs will be limited to 15%, exempts generics

Trump tariffs live updates: Trump unveils tariffs on timber, lumber, furniture; Pfizer set for reprieve

U.S. to impose 100% tariff on branded, patented drugs unless firms build plants locally, Trump says

Supreme Court steps in: Trump's emergency tariffs struck down

White House and European Union Announce Long-Awaited Details on Pharma Tariffs

Trump Pharma Tariffs Would Raise Drug Prices for Americans

Shares in European drug companies hit four-month low as Trump tariffs loom